Huntsman/$HUN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Huntsman

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives the majority of its revenue from the Polyurethanes segment,t which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

Ticker

$HUN
Sector

Primary listing

NYSE

Industry

Chemicals

Employees

6,300

ISIN

US4470111075

Huntsman Metrics

BasicAdvanced
$2.1B
-
-$0.91
0.84
$1.00
8.42%

What the Analysts think about Huntsman

Analyst ratings (Buy, Hold, Sell) for Huntsman stock.

Bulls say / Bears say

Huntsman Corporation's strategic focus on expanding its downstream specialty and formulation businesses, particularly in the Polyurethanes segment, positions the company for long-term growth by shifting towards higher-margin, differentiated products. (nasdaq.com)
The company's commitment to cost optimization, including achieving over $280 million in run-rate savings by the end of 2023 and targeting an additional $60 million in 2024, enhances operational efficiency and profitability. (nasdaq.com)
Huntsman's strong liquidity position, with approximately $1.3 billion in combined cash and unused borrowing capacity, provides financial flexibility to navigate market challenges and invest in growth opportunities. (stocktitan.net)
Persistent demand softness and significant de-stocking, particularly in Europe and China, have negatively impacted Huntsman's revenue and margins, with the commercial construction market's recovery expected to take years. (seekingalpha.com)
Analysts have downgraded Huntsman's stock, with a consensus rating of 'Reduce' and an average 12-month price target of $15.00, reflecting concerns over the company's near-term performance. (marketbeat.com)
The closure of the Moers maleic anhydride plant in Germany, following a $10 million loss, indicates operational challenges and potential restructuring costs that may affect the company's financial health. (stockinvest.us)
Data summarised monthly by Lightyear AI. Last updated on 9 Jul 2025.

Huntsman Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Huntsman Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HUN

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs